Skip to main content
. 2017 Jul 26;7:6630. doi: 10.1038/s41598-017-07014-0

Figure 1.

Figure 1

Bone matrix components stimulate the expression of inflammasome constituents. BMM from WT or Nlrp3 −/− mice were incubated with 50 ng/ml RANKL in the presence of CMG as a source of M-CSF. Cells pre-treated with RANKL for 2days (D2) were exposed to bone particles (BP, 125 µg/ml) or PBS for 24 hours or 72 hours (h). Cells were harvested on D0 (the first day of RANKL stimulation), D2, D3 or D5 and protein and mRNA expression was assessed. (a) Western blot analysis of NLRP3 expression. Data are representative of at least 3 independent experiments. Results are from the same gels, but the lanes were cut and pasted (see S1f). (bd) qPCR analysis of mRNA expression. Data are expressed as means ± SD, and are representative of at least 3 independent experiments. (b) ****p < 0.0001 (one-way ANOVA and Sidak’s multiple comparison test); (c) WT: ***p < 0.0005, Nlrp3 −/−: ****p < 0.0001; (d) ****p < 0.0001. (e) Western blot analysis of pathway activation. WT BMM were serum-starved overnight and stimulated with 125 µg/ml BP. Cells were harvested at the indicated time points.